TSX:JWELPersonal Products
How Influenza-Driven Demand And M&A Signals At Jamieson Wellness (TSX:JWEL) Has Changed Its Investment Story
In recent commentary, Stifel Canada analyst Justin Keywood highlighted pharmacy feedback showing a December spike in influenza cases, which he linked to potentially strong past fourth and upcoming first quarter results for Jamieson Wellness, given its meaningful Canadian revenue exposure.
Keywood also indicated that Jamieson Wellness may be preparing to restart M&A activity, a move that could expand its scale and make it a more compelling acquisition candidate.
We’ll now examine how the...